利福中國(02136.HK)中期淨利下跌67.4%至4170萬元
格隆匯8月8日丨利福中國(02136.HK)公吿,截至2024年6月30日止6個月中期業績,收入下跌7.3%至人民幣6.45億元;公司擁有人應占溢利下跌67.4%至人民幣4170萬元;每股盈利下跌67.4%至人民幣0.028元;董事會不宣派任何中期股息。
溢利下跌主要由於(i)集團應占聯營公司北人集團溢利相比去年同期下跌37.0%至人民幣96.2百萬元;(ii)集團銷售額及收入下跌;及(iii)上海久光續租物業的租賃負債產生財務費用增加。集團期內在未計及應占聯營公司及一間合資企業溢利前錄得除税前經營虧損人民幣1300萬元,而2023年同期則錄得經營溢利人民幣3410萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.